Global Chronic Heart Failure (CHF) Devices Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Implantable Left Ventricular Assist Device (LVAD)
Biventricular Pacemaker
Implantable Cardioverter-defibrillators (ICDs)
Continuous Positive Air Pressure Device (CPAP)
Bi-level Positive Air Pressure Device (BiPAP)
Heart Pumps
Segment by Application
Hospital
Clinic
Household
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Medtronic
Abbott
Johnson & Johnson
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Boston Scientific Corporation
HeartWare
Biovail Corporation
Abiomed
Symplmed Pharmaceuticals
Berlin Heart GmbH
ReliantHeart, Inc.
Cardiokinetix
Biotronik
Jarvik Heart

Table of Content
1 Chronic Heart Failure (CHF) Devices Market Overview
1.1 Product Overview and Scope of Chronic Heart Failure (CHF) Devices
1.2 Chronic Heart Failure (CHF) Devices Segment by Type
1.2.1 Global Chronic Heart Failure (CHF) Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Implantable Left Ventricular Assist Device (LVAD)
1.2.3 Biventricular Pacemaker
1.2.4 Implantable Cardioverter-defibrillators (ICDs)
1.2.5 Continuous Positive Air Pressure Device (CPAP)
1.2.6 Bi-level Positive Air Pressure Device (BiPAP)
1.2.7 Heart Pumps
1.3 Chronic Heart Failure (CHF) Devices Segment by Application
1.3.1 Chronic Heart Failure (CHF) Devices Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Global Chronic Heart Failure (CHF) Devices Market Size Estimates and Forecasts
1.4.1 Global Chronic Heart Failure (CHF) Devices Revenue 2016-2027
1.4.2 Global Chronic Heart Failure (CHF) Devices Sales 2016-2027
1.4.3 Chronic Heart Failure (CHF) Devices Market Size by Region: 2016 Versus 2021 Versus 2027
2 Chronic Heart Failure (CHF) Devices Market Competition by Manufacturers
2.1 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Chronic Heart Failure (CHF) Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Chronic Heart Failure (CHF) Devices Manufacturing Sites, Area Served, Product Type
2.5 Chronic Heart Failure (CHF) Devices Market Competitive Situation and Trends
2.5.1 Chronic Heart Failure (CHF) Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Chronic Heart Failure (CHF) Devices Players Market Share by Revenue
2.5.3 Global Chronic Heart Failure (CHF) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chronic Heart Failure (CHF) Devices Retrospective Market Scenario by Region
3.1 Global Chronic Heart Failure (CHF) Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Chronic Heart Failure (CHF) Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Chronic Heart Failure (CHF) Devices Market Facts & Figures by Country
3.3.1 North America Chronic Heart Failure (CHF) Devices Sales by Country
3.3.2 North America Chronic Heart Failure (CHF) Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Chronic Heart Failure (CHF) Devices Market Facts & Figures by Country
3.4.1 Europe Chronic Heart Failure (CHF) Devices Sales by Country
3.4.2 Europe Chronic Heart Failure (CHF) Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Chronic Heart Failure (CHF) Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Region
3.5.2 Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Chronic Heart Failure (CHF) Devices Market Facts & Figures by Country
3.6.1 Latin America Chronic Heart Failure (CHF) Devices Sales by Country
3.6.2 Latin America Chronic Heart Failure (CHF) Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Chronic Heart Failure (CHF) Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Country
3.7.2 Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Chronic Heart Failure (CHF) Devices Historic Market Analysis by Type
4.1 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2016-2021)
4.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2016-2021)
4.3 Global Chronic Heart Failure (CHF) Devices Price by Type (2016-2021)
5 Global Chronic Heart Failure (CHF) Devices Historic Market Analysis by Application
5.1 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2016-2021)
5.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2016-2021)
5.3 Global Chronic Heart Failure (CHF) Devices Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medtronic Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Abbott Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Johnson & Johnson Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Stanley Pharmaceuticals
6.4.1 Stanley Pharmaceuticals Corporation Information
6.4.2 Stanley Pharmaceuticals Description and Business Overview
6.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Stanley Pharmaceuticals Product Portfolio
6.4.5 Stanley Pharmaceuticals Recent Developments/Updates
6.5 New Haven Pharmaceuticals, Inc.
6.5.1 New Haven Pharmaceuticals, Inc. Corporation Information
6.5.2 New Haven Pharmaceuticals, Inc. Description and Business Overview
6.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 New Haven Pharmaceuticals, Inc. Product Portfolio
6.5.5 New Haven Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Boston Scientific Corporation
6.6.1 Boston Scientific Corporation Corporation Information
6.6.2 Boston Scientific Corporation Description and Business Overview
6.6.3 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Boston Scientific Corporation Product Portfolio
6.6.5 Boston Scientific Corporation Recent Developments/Updates
6.7 HeartWare
6.6.1 HeartWare Corporation Information
6.6.2 HeartWare Description and Business Overview
6.6.3 HeartWare Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 HeartWare Product Portfolio
6.7.5 HeartWare Recent Developments/Updates
6.8 Biovail Corporation
6.8.1 Biovail Corporation Corporation Information
6.8.2 Biovail Corporation Description and Business Overview
6.8.3 Biovail Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biovail Corporation Product Portfolio
6.8.5 Biovail Corporation Recent Developments/Updates
6.9 Abiomed
6.9.1 Abiomed Corporation Information
6.9.2 Abiomed Description and Business Overview
6.9.3 Abiomed Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Abiomed Product Portfolio
6.9.5 Abiomed Recent Developments/Updates
6.10 Symplmed Pharmaceuticals
6.10.1 Symplmed Pharmaceuticals Corporation Information
6.10.2 Symplmed Pharmaceuticals Description and Business Overview
6.10.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Symplmed Pharmaceuticals Product Portfolio
6.10.5 Symplmed Pharmaceuticals Recent Developments/Updates
6.11 Berlin Heart GmbH
6.11.1 Berlin Heart GmbH Corporation Information
6.11.2 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Description and Business Overview
6.11.3 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Berlin Heart GmbH Product Portfolio
6.11.5 Berlin Heart GmbH Recent Developments/Updates
6.12 ReliantHeart, Inc.
6.12.1 ReliantHeart, Inc. Corporation Information
6.12.2 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Description and Business Overview
6.12.3 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 ReliantHeart, Inc. Product Portfolio
6.12.5 ReliantHeart, Inc. Recent Developments/Updates
6.13 Cardiokinetix
6.13.1 Cardiokinetix Corporation Information
6.13.2 Cardiokinetix Chronic Heart Failure (CHF) Devices Description and Business Overview
6.13.3 Cardiokinetix Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Cardiokinetix Product Portfolio
6.13.5 Cardiokinetix Recent Developments/Updates
6.14 Biotronik
6.14.1 Biotronik Corporation Information
6.14.2 Biotronik Chronic Heart Failure (CHF) Devices Description and Business Overview
6.14.3 Biotronik Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Biotronik Product Portfolio
6.14.5 Biotronik Recent Developments/Updates
6.15 Jarvik Heart
6.15.1 Jarvik Heart Corporation Information
6.15.2 Jarvik Heart Chronic Heart Failure (CHF) Devices Description and Business Overview
6.15.3 Jarvik Heart Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Jarvik Heart Product Portfolio
6.15.5 Jarvik Heart Recent Developments/Updates
7 Chronic Heart Failure (CHF) Devices Manufacturing Cost Analysis
7.1 Chronic Heart Failure (CHF) Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Chronic Heart Failure (CHF) Devices
7.4 Chronic Heart Failure (CHF) Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Chronic Heart Failure (CHF) Devices Distributors List
8.3 Chronic Heart Failure (CHF) Devices Customers
9 Chronic Heart Failure (CHF) Devices Market Dynamics
9.1 Chronic Heart Failure (CHF) Devices Industry Trends
9.2 Chronic Heart Failure (CHF) Devices Growth Drivers
9.3 Chronic Heart Failure (CHF) Devices Market Challenges
9.4 Chronic Heart Failure (CHF) Devices Market Restraints
10 Global Market Forecast
10.1 Chronic Heart Failure (CHF) Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Chronic Heart Failure (CHF) Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Chronic Heart Failure (CHF) Devices by Type (2022-2027)
10.2 Chronic Heart Failure (CHF) Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Chronic Heart Failure (CHF) Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Chronic Heart Failure (CHF) Devices by Application (2022-2027)
10.3 Chronic Heart Failure (CHF) Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Chronic Heart Failure (CHF) Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Chronic Heart Failure (CHF) Devices by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figure
List of Tables
Table 1. Global Chronic Heart Failure (CHF) Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Chronic Heart Failure (CHF) Devices Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Chronic Heart Failure (CHF) Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Chronic Heart Failure (CHF) Devices Covered in This Study
Table 5. Global Chronic Heart Failure (CHF) Devices Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Chronic Heart Failure (CHF) Devices Sales Share by Manufacturers (2016-2021)
Table 7. Global Chronic Heart Failure (CHF) Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Chronic Heart Failure (CHF) Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Chronic Heart Failure (CHF) Devices Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Chronic Heart Failure (CHF) Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Chronic Heart Failure (CHF) Devices Product Type
Table 12. Global Chronic Heart Failure (CHF) Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Chronic Heart Failure (CHF) Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Heart Failure (CHF) Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Chronic Heart Failure (CHF) Devices Sales by Region (2016-2021) & (K Units)
Table 16. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2016-2021)
Table 17. Global Chronic Heart Failure (CHF) Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Chronic Heart Failure (CHF) Devices Sales by Country (2016-2021) & (K Units)
Table 19. North America Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2016-2021)
Table 20. North America Chronic Heart Failure (CHF) Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Chronic Heart Failure (CHF) Devices Sales by Country (2016-2021) & (K Units)
Table 23. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Chronic Heart Failure (CHF) Devices Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Chronic Heart Failure (CHF) Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Chronic Heart Failure (CHF) Devices Sales (K Units) by Type (2016-2021)
Table 39. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2016-2021)
Table 40. Global Chronic Heart Failure (CHF) Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Chronic Heart Failure (CHF) Devices Revenue Share by Type (2016-2021)
Table 42. Global Chronic Heart Failure (CHF) Devices Price (US$/Unit) by Type (2016-2021)
Table 43. Global Chronic Heart Failure (CHF) Devices Sales (K Units) by Application (2016-2021)
Table 44. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2016-2021)
Table 45. Global Chronic Heart Failure (CHF) Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Chronic Heart Failure (CHF) Devices Revenue Share by Application (2016-2021)
Table 47. Global Chronic Heart Failure (CHF) Devices Price (US$/Unit) by Application (2016-2021)
Table 48. Medtronic Corporation Information
Table 49. Medtronic Description and Business Overview
Table 50. Medtronic Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Medtronic Chronic Heart Failure (CHF) Devices Product
Table 52. Medtronic Recent Developments/Updates
Table 53. Abbott Corporation Information
Table 54. Abbott Description and Business Overview
Table 55. Abbott Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Abbott Chronic Heart Failure (CHF) Devices Product
Table 57. Abbott Recent Developments/Updates
Table 58. Johnson & Johnson Corporation Information
Table 59. Johnson & Johnson Description and Business Overview
Table 60. Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Johnson & Johnson Chronic Heart Failure (CHF) Devices Product
Table 62. Johnson & Johnson Recent Developments/Updates
Table 63. Stanley Pharmaceuticals Corporation Information
Table 64. Stanley Pharmaceuticals Description and Business Overview
Table 65. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product
Table 67. Stanley Pharmaceuticals Recent Developments/Updates
Table 68. New Haven Pharmaceuticals, Inc. Corporation Information
Table 69. New Haven Pharmaceuticals, Inc. Description and Business Overview
Table 70. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product
Table 72. New Haven Pharmaceuticals, Inc. Recent Developments/Updates
Table 73. Boston Scientific Corporation Corporation Information
Table 74. Boston Scientific Corporation Description and Business Overview
Table 75. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product
Table 77. Boston Scientific Corporation Recent Developments/Updates
Table 78. HeartWare Corporation Information
Table 79. HeartWare Description and Business Overview
Table 80. HeartWare Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. HeartWare Chronic Heart Failure (CHF) Devices Product
Table 82. HeartWare Recent Developments/Updates
Table 83. Biovail Corporation Corporation Information
Table 84. Biovail Corporation Description and Business Overview
Table 85. Biovail Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Biovail Corporation Chronic Heart Failure (CHF) Devices Product
Table 87. Biovail Corporation Recent Developments/Updates
Table 88. Abiomed Corporation Information
Table 89. Abiomed Description and Business Overview
Table 90. Abiomed Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Abiomed Chronic Heart Failure (CHF) Devices Product
Table 92. Abiomed Recent Developments/Updates
Table 93. Symplmed Pharmaceuticals Corporation Information
Table 94. Symplmed Pharmaceuticals Description and Business Overview
Table 95. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product
Table 97. Symplmed Pharmaceuticals Recent Developments/Updates
Table 98. Berlin Heart GmbH Corporation Information
Table 99. Berlin Heart GmbH Description and Business Overview
Table 100. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product
Table 102. Berlin Heart GmbH Recent Developments/Updates
Table 103. ReliantHeart, Inc. Corporation Information
Table 104. ReliantHeart, Inc. Description and Business Overview
Table 105. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product
Table 107. ReliantHeart, Inc. Recent Developments/Updates
Table 108. Cardiokinetix Corporation Information
Table 109. Cardiokinetix Description and Business Overview
Table 110. Cardiokinetix Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Cardiokinetix Chronic Heart Failure (CHF) Devices Product
Table 112. Cardiokinetix Recent Developments/Updates
Table 113. Biotronik Corporation Information
Table 114. Biotronik Description and Business Overview
Table 115. Biotronik Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Biotronik Chronic Heart Failure (CHF) Devices Product
Table 117. Biotronik Recent Developments/Updates
Table 118. Jarvik Heart Corporation Information
Table 119. Jarvik Heart Description and Business Overview
Table 120. Jarvik Heart Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Jarvik Heart Chronic Heart Failure (CHF) Devices Product
Table 122. Jarvik Heart Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Chronic Heart Failure (CHF) Devices Distributors List
Table 126. Chronic Heart Failure (CHF) Devices Customers List
Table 127. Chronic Heart Failure (CHF) Devices Market Trends
Table 128. Chronic Heart Failure (CHF) Devices Growth Drivers
Table 129. Chronic Heart Failure (CHF) Devices Market Restraints
Table 130. Global Chronic Heart Failure (CHF) Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 131. Global Chronic Heart Failure (CHF) Devices Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Chronic Heart Failure (CHF) Devices Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Chronic Heart Failure (CHF) Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 135. Global Chronic Heart Failure (CHF) Devices Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Chronic Heart Failure (CHF) Devices Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Chronic Heart Failure (CHF) Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 139. Global Chronic Heart Failure (CHF) Devices Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Chronic Heart Failure (CHF) Devices Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chronic Heart Failure (CHF) Devices
Figure 2. Global Chronic Heart Failure (CHF) Devices Market Share by Type in 2020 & 2027
Figure 3. Implantable Left Ventricular Assist Device (LVAD) Product Picture
Figure 4. Biventricular Pacemaker Product Picture
Figure 5. Implantable Cardioverter-defibrillators (ICDs) Product Picture
Figure 6. Continuous Positive Air Pressure Device (CPAP) Product Picture
Figure 7. Bi-level Positive Air Pressure Device (BiPAP) Product Picture
Figure 8. Heart Pumps Product Picture
Figure 9. Global Chronic Heart Failure (CHF) Devices Market Share by Application in 2020 & 2027
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Household
Figure 13. Others
Figure 14. Global Chronic Heart Failure (CHF) Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Chronic Heart Failure (CHF) Devices Market Size 2016-2027 (US$ Million)
Figure 16. Global Chronic Heart Failure (CHF) Devices Sales 2016-2027 (K Units)
Figure 17. Global Chronic Heart Failure (CHF) Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Chronic Heart Failure (CHF) Devices Sales Share by Manufacturers in 2020
Figure 19. Global Chronic Heart Failure (CHF) Devices Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Chronic Heart Failure (CHF) Devices Players: Market Share by Revenue in 2020
Figure 21. Chronic Heart Failure (CHF) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2016-2021)
Figure 23. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Region in 2020
Figure 24. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Region (2016-2021)
Figure 25. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Region in 2020
Figure 26. U.S. Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. UAE Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Chronic Heart Failure (CHF) Devices by Type (2016-2021)
Figure 51. Sales Market Share of Chronic Heart Failure (CHF) Devices by Application (2016-2021)
Figure 52. Sales Market Share of Chronic Heart Failure (CHF) Devices by Application in 2020
Figure 53. Revenue Share of Chronic Heart Failure (CHF) Devices by Application (2016-2021)
Figure 54. Revenue Share of Chronic Heart Failure (CHF) Devices by Application in 2020
Figure 55. Manufacturing Cost Structure of Chronic Heart Failure (CHF) Devices
Figure 56. Manufacturing Process Analysis of Chronic Heart Failure (CHF) Devices
Figure 57. Chronic Heart Failure (CHF) Devices Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed